Find Your Funding Opportunity
Notice of Intent to Publish a Funding Opportunity Announcement for Blueprint Neurotherapeutics Network (BPN): Biologic-based Drug Discovery and Development for Disorders of the Nervous System (UG3/UH3 Clinical Trial Optional)
Service
|
Source |
Final Application Due Date |
Funding Available
|
Match Required
|
|---|---|---|---|---|
| Health Care |
Federal
HHS |
01-27-2025 | N/A | No Match Required |
-
Service
-
Source
-
Final Application Due Date
-
Funding Available
-
Match Required
Status
- Opportunity Type Discretionary
- CFDA N/A
Description
The NIH announces its intention to reissue PAR-21-163 to solicit applications from researchers developing diverse biotherapeutic modalities � including but not limited to antibodies, peptides, proteins, oligonucleotides, gene therapies, cell therapies, and other emerging therapeutic modalities � for the treatment of nervous system and neuromuscular disorders. This Notice is being provided to allow potential applicants sufficient time to develop meaningful collaborations and responsive projects.� The NOFO is expected to be published in Fall 2024 with an expected application due date in Winter 2025. This NOFO will utilize the UG3/UH3 activity code. Details of the planned NOFO are provided below.
Eligibility
- IHE
- Local Government
- Non-Profit
- Other
- State Government
- Tribal Government
Key Date(s)
- August 26, 2024: Forecasted Date
- October 01, 2024: Estimated Post Date
- January 27, 2025: Estimated Application Due Date
- December 01, 2025: Estimated Project Start Date
- December 01, 2025: Estimated Award Date